Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder
Status:
Unknown status
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The objectives of the current study are
1. to evaluate the efficacy of escitalopram in treatment for post-traumatic stress
disorder,
2. to find the structural changes of brain using magnetic resonance imaging and its
association with the symptoms reduction, and
3. to look at the differences of brain imaging findings and symptoms changes according to
genetic differences of brain-derived neurotrophic factor (a biological molecule
facilitating neuronal growth in human).